Corona Remedies Ltd
Company Profile
Business description
Corona Remedies Ltd is a pharmaceutical formulation company engaged in developing, manufacturing, and marketing products in women's healthcare, cardio-diabetes, pain management, urology, and other therapeutic areas. The company offers products across the following therapeutic areas: women's health, cardio-diabetes, pain management, urology, and others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal, and respiratory). The company operates in only one reportable business segment, i.e., pharmaceuticals. It generates a substantial portion of its revenue from operations in certain therapeutic areas in India, with the majority coming from women's healthcare.
Contact
S. G. Highway, CORONA House
C - Mondeal Business Park, Near Gurudwara
Thaltej
AhmedabadGJ380 059
INDT: +91 7940233000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
4,573
Stocks News & Analysis
stocks
Chart of the Week: Has gold reached bear market territory?
stocks
Fair value upgrade for this ASX income player
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,885.60 | 59.90 | 0.68% |
| CAC 40 | 7,981.27 | 164.33 | 2.10% |
| DAX 40 | 23,298.89 | 618.85 | 2.73% |
| Dow JONES (US) | 46,792.70 | 1,576.56 | 3.49% |
| FTSE 100 | 10,364.79 | 188.34 | 1.85% |
| HKSE | 25,294.03 | 505.89 | 2.04% |
| NASDAQ | 21,972.98 | 1,178.34 | 5.67% |
| Nikkei 225 | 53,739.68 | 2,675.96 | 5.24% |
| NZX 50 Index | 12,825.87 | 86.24 | -0.67% |
| S&P 500 | 6,608.24 | 79.72 | 1.22% |
| S&P/ASX 200 | 8,671.80 | 53.10 | 0.62% |
| SSE Composite Index | 3,948.55 | 56.69 | 1.46% |